EXECUTIVE
SUMMARY
i. Clinical
Overview
ii. European Markets for
Transfusion Management Products
a. Blood Salvage/Autotransfusion Systems
b. Blood
Substitutes/Intravascular Oxygen Carriers
c. Plasma Volume Expanders
iii. Market Analysis
iv. Methodology
Exhibit
ES-1: Europe, Transfusion Management Products, Combined Market Forecast,
2008-2013
1.
EUROPEAN HEALTHCARE MARKETS
1.1 The
European Union
1.1.1 A Common Currency
1.1.2 Regulatory Policies
1.1.3 Reimbursement
1.1.4 Healthcare Spending
1.2
Selected European National Healthcare Profiles
1.2.1 France
1.2.1.1 Healthcare Organization and Reform
1.2.1.2 Hospital Services
1.2.1.3 Medical Device Reimbursement
1.2.2 Germany
1.2.2.1 Healthcare Organization and Reform
1.2.2.2 Hospital Services
1.2.2.3 Medical Device Reimbursement
1.2.3 Italy
1.2.3.1 Healthcare Organization and Reform
1.2.3.2 Hospital Services
1.2.3.3 Medical Device Reimbursement
1.2.4 Spain
1.2.4.1 Healthcare Organization and Reform
1.2.4.2 Hospital Services
1.2.4.3 Medical Device Reimbursement
1.2.5 United Kingdom
1.2.5.1 Healthcare Organization and Reform
1.2.5.2 Hospital Services
1.2.5.3 Medical Device Reimbursement
Exhibit 1-1: European Union,
Medical Devices Risk Classification System
Exhibit 1-2: Europe,
Population Statistics Comparison for the Years 2008 and 2018
Exhibit 1-3: France, Selected National Healthcare Statistics
Exhibit 1-4: Germany, Selected National Healthcare Statistics
Exhibit 1-5: Italy, Selected National Healthcare Statistics
Exhibit 1-6: Spain, Selected National Healthcare Statistics
Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics
2. OVERVIEW OF THE CRITICAL CARE
ENVIRONMENT
2.1
Conditions Treated in the Critical Care Unit
2.2
Critical Care Unit Staffing
2.2.1 Intensivists
2.2.2 Nurses and Other Allied
Healthcare Professionals
2.3 Critical
Care Units, by Size and Type
2.4 Equipment and Products Used in
the Critical Care Setting
2.4.1 Invasive and Noninvasive
Equipment and Products
2.4.2 Transport Equipment and
Products
2.5
Critical Access Hospital Designation
2.6 Issues
Affecting Critical Care Delivery
2.6.1 Patient Demographics
2.6.2 Managed Care
2.6.3 Healthcare Personnel
Shortages
2.6.4 Trends in Critical Care
Product Purchasing
Exhibit 2-1: 2006, Number of
Anesthetists/Intensivists in Selected European Countries
Exhibit 2-2: Selected Critical
Care Nursing and Allied Healthcare Responsibilities
Exhibit 2-3: 2006, Number of
Emergency Rooms and Beds in Selected European Countries
Exhibit 2-4: 2006, Total
Equipped Positions, by Type of Intensive Care Unit and Facility in Selected European
Countries
Exhibit 2-5: 2006, France, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-6: 2006, Germany, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-7: 2006, Italy, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-8: 2006, Spain, Total Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-9: 2006, United
Kingdom, Total Equipped Positions, by Type of Intensive Care Unit and Facility
3. EUROPEAN MARKETS FOR TRANSFUSION
MANAGEMENT PRODUCTS
3.1
Clinical Overview
3.1.1 Banked Blood Supply
3.1.2 Allogeneic and Autologous
Blood Transfusions
3.1.3 Blood Bank Product Safety and
Testing Protocols
3.1.4 Blood Components
3.1.5 Incidence of Blood Transfusions
3.2 Blood
Salvage/Autotransfusion Systems
3.2.1 Applications
3.2.2 Costs
3.2.3 Risks
3.2.4 Intraoperative and
Postoperative Blood Salvage
3.2.5 Market Forecast
3.2.6 Competitive Analysis
3.3 Blood
Substitutes/Intravascular Oxygen Carriers
3.4 Plasma
Volume Expanders
3.4.1 Colloid Solutions
3.4.1.1 Human Serum Albumin
3.4.1.2 Plasma Protein Fraction
3.4.1.3 Hydroxyethyl Starch
3.4.1.4 Dextran
3.4.1.5 Gelatin
3.4.2 Crystalloid Solutions
3.4.2.1 Normal Saline
3.4.2.2 Dextrose Solutions
3.4.2.3 Hartmann’s Solution
3.4.3 Market Forecast
3.4.4 Competitive Analysis
3.5
Combined Market Forecast
Exhibit 3-1: 2009, Selected
Blood Salvage/Autotransfusion Systems
Exhibit 3-2: Europe, Blood
Salvage Systems, Combined Market Forecast, 2008-2013
Exhibit 3-3: Europe, Blood
Salvage Equipment, Market Forecast, 2008-2013
Exhibit 3-4: Europe, Blood
Salvage Disposables, Market Forecast, 2008-2013
Exhibit 3-5: 2008, Blood
Salvage Products Market, Share by Supplier
Exhibit 3-6: 2009, Types of
Plasma Volume Expanders and Their Indications
Exhibit 3-7: 2009, Selected
Plasma Volume Expanders
Exhibit 3-8: Europe, Plasma
Volume Expanders, Combined Market Forecast, 2008-2013
Exhibit 3-9: Europe, Colloids,
Market Forecast, 2008-2013
Exhibit 3-10: Europe,
Crystalloids, Market Forecast, 2008-2013
Exhibit 3-11: Europe,
Transfusion Management Products, Combined Market Forecast, 2008-2013
4.
COMPANY PROFILES
4.1 Baxter
International, Inc.
4.2 B.
Braun Melsungen AG
4.3 CSL
Behring LLC/CSL LTD
4.4 Fresenius
SE
4.5 Grifols
SA
4.6 Haemonetics
Corporation
4.7 Oxygen
Biotherapeutics, Inc.
4.8 Sangart,
Inc.
4.9 Sorin
SPA
4.10 Talecris
Biotherapeutics, Inc.
APPENDIX:
COMPANY LISTING